Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Patients suffering from HCC are usually diagnosed during an advanced stage, which limits the effectiveness of treatment. This phenomenon has led to an urgent need to discover promising HCC diagnostic biomarkers and to identify novel targets for HCC treatment.

中文翻译：

---

在肝细胞癌关键基因和特定途径的计算机鉴定中。

背景：肝细胞癌（HCC）是全球范围内与癌症相关的死亡的主要原因之一。通常在晚期阶段诊断患有HCC的患者，这限制了治疗的有效性。这种现象导致迫切需要发现有希望的HCC诊断生物标志物，并确定HCC治疗的新靶标。